Clinical Trials Packaging Seed-To-Sale Treatment 
Cannabis Law Report
OCTOBER 6, 2021
NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.
Cannabis Law Report
DECEMBER 18, 2019
CannEpil is the company’s high cannabidiol and low tetrahydrocannabinol, phytocannabinoid-derived formulation, used in the treatment of drug-resistant epilepsy. In particular, the money is being used to support a clinical trial for its CogniCann product that is being run alongside the University of Notre Dame in Western Australia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JUNE 9, 2022
We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. Forbes write.
Cannabis Law Report
DECEMBER 20, 2021
Hemp , scientifically defined as Cannabis sativa , is a plant, each part of which can be put to use: the stalk, seeds, and flowers. It is also called industrial hemp , plant of the family Cannabaceae cultivated for its bast fibre or its edible seeds 1. As published via the Mondaq Platform. 20 December 2021. by Chitwandeep Kaur.
Cannabis Law Report
OCTOBER 17, 2019
As more countries legalize or decriminalize the cultivation, manufacture, sale, and use of cannabis, companies across a variety of industries are looking for opportunities to capitalize on this emerging market. Selinger cites software, point-of-sale systems, and packaging as areas that are thriving in the state.
Expert insights. Personalized for you.
52 
Let's personalize your content